ENDOSCOPIC ND-YAG LASER THERAPY FOR ACTIVE ESOPHAGEAL VARICEAL BLEEDING - A RANDOMIZED CONTROLLED-STUDY
ENDOSCOPIC ND-YAG LASER THERAPY FOR ACTIVE ESOPHAGEAL VARICEAL BLEEDING - A RANDOMIZED CONTROLLED-STUDY
复制标题
DOI:
10.1016/s0016-5107(85)71954-2
复制
发表时间:
1985-01-01
影响因子:
7.7
通讯作者:
FLEISCHER, D
中科院分区:
文献类型:
--
作者:
FLEISCHER, D
A randomized controlled double-blind study was undertaken to assess the efficacy and safety of endoscopic neodymium:yttrium aluminum garnet (Nd:YAG) laser therapy for active esophageal variceal bleeding. Ten patients were randomized to the laser treatment group and 10 to a control group that received sham endoscopy and standard medical therapy. Initial hemostasis was achieved in 7 laser-treated patients and in 0 controls receiving sham treatment (P < 0.002). Four of the 7 who were initially controlled with laser therapy had rebleeding 12-48 h later; 3 of 10 laser patients had lasting hemostasis. The mean blood transfusion requirements were similar in both groups (laser = 7.3 U; control = 7.8 U). Six of the 10 laser-treated patients were discharged from the hospital and 4 died. There were 7 hospital deaths in the control group and 3 patients were discharged (P = 0.22). In 2 patients in the treatment group, laser therapy increased bleeding. There were no perforations.